Not logged inCemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA
Gerard, E.; Lebbe, C.; Lanoy, E.; Quereux, G.; Bernard, P.; Viguier, M-A.; Meyer, N.; Mortier, L.; Dinulescu, M.; Legoupil, D.; Neidhardt, E. M.; Saiag, P.; Trabelsi-Messai, S.; Celerier, P.; Nardin, C.; Maubec, E.; Wierzbicka, E. Hainaut; Perrier, S.; Garnier, S.; Robert, C.
Share
Save
Share
SaveCirculating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study
Sabatier, R.; Pomel, C.; Colombo, P-E.; Narducci, F.; Garnier, S.; Carbuccia, N.; Guille, A.; Birnbaum, D.; Zemmour, C.; Lambaudie, E.
Share
SaveA major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine
Seguin, L.; Chaffanet, M.; Sabatier, R.; Jose, A.; Garnier, S.; Carbuccia, N.; Guille, A.; Birnbaum, D.; Bertucci, F.; Goncalves, A.
Share
SaveRevisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification
Cervera, N.; Carbuccia, N.; Mozziconacci, M-J; Adelaide, J.; Garnier, S.; Guille, A.; Murati, A.; Chaffanet, M.; Vey, N.; Birnbaum, D.; Gelsi-Boyer, V.
Share
SaveMolecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing
Cervera, N.; Carbuccia, N.; Garnier, S.; Guille, A.; Adelaide, J.; Murati, A.; Vey, N.; Mozziconacci, M-J; Chaffanet, M.; Birnbaum, D.; Gelsi-Boyer, V.
Share
SaveDrug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
Collette, Y.; Prebet, T.; Goubard, A.; Adelaide, J.; Castellano, R.; Carbuccia, N.; Garnier, S.; Guille, A.; Arnoulet, C.; Charbonier, A.; Mozziconacci, M. J.; Birnbaum, D.; Chaffanet, M.; Vey, N.
Share
Save
Share
Save